Ocugen (OCGN) Non-Current Assets (2014 - 2026)
Ocugen (OCGN) posted Non-Current Assets of $18.4 million for Q1 2026, down 4.29% on a QoQ basis from $19.2 million in Q4 2025, and down 10.45% year-over-year from $20.5 million in Q1 2025.
Ocugen (OCGN) Non-Current Assets (2014 - 2026) Analysis & Trends
Ocugen's Non-Current Assets history runs 13 years deep, the most recent figure standing at $18.4 million for Q1 2026.
- Quarterly Non-Current Assets fell 10.45% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.2 million (down 7.4% YoY) and the FY2025 annual result came in at $19.2 million, down 7.63% from the prior year.
- Non-Current Assets was $18.4 million for Q1 2026 at Ocugen, down from $19.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $21.9 million in Q2 2024 and bottomed at $3.7 million in Q1 2022.
- A 5-year average of $16.6 million and a median of $19.2 million in 2025 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 225.52% — and 2026, when it slipped 10.45%.
- Ocugen's Non-Current Assets stood at $10.1 million in 2022, then jumped by 112.78% to $21.6 million in 2023, then dropped by 3.78% to $20.8 million in 2024, then decreased by 7.63% to $19.2 million in 2025, then slipped by 4.29% to $18.4 million in 2026.
- Business Quant data shows OCGN's Non-Current Assets at $18.4 million in Q1 2026, $19.2 million in Q4 2025, and $20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.35 Mn |
| Dec 31, 2025 | 19.18 Mn |
| Sep 30, 2025 | 19.96 Mn |
| Jun 30, 2025 | 20.71 Mn |
| Mar 31, 2025 | 20.50 Mn |
| Dec 31, 2024 | 20.76 Mn |
| Sep 30, 2024 | 21.26 Mn |
| Jun 30, 2024 | 21.93 Mn |
| Mar 31, 2024 | 21.80 Mn |
| Dec 31, 2023 | 21.58 Mn |
| Sep 30, 2023 | 18.13 Mn |
| Jun 30, 2023 | 15.52 Mn |
| Mar 31, 2023 | 11.90 Mn |
| Dec 31, 2022 | 10.14 Mn |
| Sep 30, 2022 | 8.74 Mn |
| Jun 30, 2022 | 7.52 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 2.86 Mn |
| Jun 30, 2021 | 2.63 Mn |